top of page
Our Studies
Current Ongoing Studies
Abbott Diabetes Care
ADC-US-RES-21212-001
HbA1c Variation Study
Abbott Infectious Disease
2118001
Nasal Swab Collection in Patients Symptomatic of or Confirmed Positive for COVID-19, Influenza A, or Influenza B-*
Abbott Point of Care
CS-2021-0019
Clinical Evaluation of pH, PCO2 and PO2 in Capillary Specimens using the i-STAT CG4+ Cartridge on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2021-0017
Clinical Evaluation of pH, PCO2 and PO2 in Capillary Specimens using the i-STAT G3+ Cartridge on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2022-0003
Clinical Evaluation of Precision for the i-STAT CG4+ Cartridge with Capillary Specimens on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2020-0012
Clinical Evaluation of the i-STAT hs-TnI Test to Aid in the Diagnosis of Myocardial Infarction (MI)
Abbott Point of Care
CS-2021-0007
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge and i-STAT 1 Analyzer
Abbott Point of Care
CS-2022-0002
Clinical Evaluation of Precision for the i-STAT G3+ Cartridge with Capillary Specimens on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2020-0010
Clinical Evaluation of the i-STAT G3+ Cartridge for Non- Anticoagulated Venous and Arterial Whole Blood Specimens on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2021-0003
Clinical Evaluation of the Creatinine Test in Venous, Arterial and Capillary Specimens using the i-STAT Crea Cartridge on the i-STAT 1 Analyzer.
Abbott Point of Care
CS-2022-0006
Clinical Evaluation of Lactate in Capillary Specimens using the i-STAT CG4+ Cartridge on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2021-0020
Clinical Evaluation of pH, PCO2 and PO2 in Capillary Specimens using the i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2021-0014
Clinical Evaluation of pH, pCO2 and pO2 Tests in Venous and Arterial Specimens using the i-STAT G3+ Cartridge on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2022-0005
Clinical Evaluation of Sodium, Potassium, Ionized Calcium, Glucose, and Hematocrit in Capillary Specimens using the i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2022-0004
Clinical Evaluation of Precision for the i-STAT CG8+ Cartridge with Capillary Specimens on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2021-0012
Clinical Evaluation of pH, pCO2, pO2, Sodium, Potassium, Ionized Calcium, Glucose, and Hematocrit Tests in Venous and Arterial Specimens using the i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer
Abbott Point of Care
CS-2021-0009
Clinical Evaluation of the i-STAT CG4+ Cartridge for Non-Anticoagulated Venous and Arterial Whole Blood Specimens on the i-STAT 1 Analyzer
Adamis Pharmaceuticals Corporation
APC400-03
A Phase 2/3, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of Tempol (MBM-02) in Subjects with COVID-19 Infection
Cue Health Inc.
CP-COVID-200
Clinical Study of the Cue® COVID-19 Test for Home and Over The Counter (OTC) Use with Lay Users Self-Testing in a Simulated Home Use Setting.
Eli Lilly and Company
J2X-MC-PYAH(g)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy with Monoclonal Antibodies in Participants with Mild to Moderate COVID-19 Illness (BLAZE-4)
Eli Lilly and Company
J2W-MC-PYAB(m)
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants with Mild to Moderate COVID-19 Illness
Eli Lilly and Company
J2A-MC-GZGE
A Phase 2 Study of Once-Daily LY3502970 Compared with Placebo and OnceWeekly Dulaglutide in Participants with Type 2 Diabetes Mellitus
Fujirebio Diagnostics, Inc.
FDI-213
A Prospective Collection of Peripheral Blood from Adults for CYFRA 21-1, SCC and NSE Assay Reference Range Determination
OraSure Technologies, Inc.
CS-1394-01
A Multicenter Study Conducted to Evaluate the Performance of the InteliSwab® COVID-19 Rapid Test
Proof Diagnostics, Inc.
PDx-1240-01
Procurement of Clinical Specimens to Evaluate the Performance of the Proof Diagnostics Multi-Analyte Test System
Tosoh Bioscience, Inc.
TBI-CLBNP-CI-PR001
Clinical Investigation of CL AIA-PACK BNP Assay on K2EDTA Plasma Specimens from ED and Non-ED Sites Using the Tosoh AIA-CL Analyzers
Turtle Shell Technologies Pvt Ltd.
DOZ-22-001
Pilot Clinical Evaluation of Dozee VS in Patients in Hospital Beds
Visby Medical, Inc.
TP–000547
Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA
Visby Medical, Inc.
TP-000312
A Prospective Study to Collect Samples for Research and Development of Visby Medical Products Relating to Respiratory Infections
Wondfo USA Co., Ltd.
CS-1382-01
Clinical Investigation for Preview® COVID-19 Rapid Antigen Test for OTC Use
Previous Studies
Abbott Laboratories
09DY-02-17TNI-02
Alinity i STAT hsTnI Design Validation Protocol
Abbott Laboratories
Alinity hq Reproducibility Study Protocol
Abbott Laboratories
T688-02-20B03-01
Alinity h-series Design Validation Clinical Study Protocol
Abbott Laboratories
T688-02-20B01-01
Alinity h-series Beta Study Protocol
Abbott Laboratories Clinical Research Department
T688-02-20B01-01
Alinity h-series Beta Study Protocol
Abbott Point of Care
CS-2021-0021
Pilot Clinical Evaluation of the i-STAT G3+ Cartridge for Assessment of Blood Gases (pO2, pCO2, pH Tests) with Capillary Specimens
Abbott Point of Care
CS-2020-0004
Clinical Evaluation of the i-STAT CHEM8+ Test Cartridge for Non-Anticoagulated Venous and Arterial Whole Blood Specimens
Abbott Point of Care
CS-2021-0014
Clinical Evaluation of pH, pCO2 and pO2 Tests in Venous and Arterial Specimens using the i-STAT G3+ Cartridge on the i-STAT 1 Analyzer.
Abbott Point of Care
CS-2020-0005
Clinical Evaluation of the i-STAT CG4+ Test Cartridge for Non-Anticoagulated Venous and Arterial Whole Blood Specimens
Abbott Point of Care
CS-2020-0010
Clinical Evaluation of the i-STAT G3+ Cartridge for Non-Anticoagulated Venous and Arterial Whole Blood Specimens.
Abbott Point of Care
CS-2020-0009
Clinical Evaluation of pH, pCO2 and pO2 Tests in Venous and Arterial Specimens using the i-STAT G3+ Cartridge
Abbott Point of Care
CS-2020-0012
Clinical Evaluation of the i-STAT hs-TnI Test to Aid in the Diagnosis of Myocardial Infarction (MI)
Abbott Point of Care
CS-2021-0003
Clinical Evaluation of the Creatinine Test in Venous, Arterial and Capillary Specimens using the i-STAT Crea Cartridge on the i-STAT 1 Analyzer.
Abbott Point of Care
CS-2021-0009
Clinical Evaluation of the i-STAT CG4+ Cartridge for Non-Anticoagulated Venous and Arterial Whole Blood Specimens on the i-STAT 1 Analyzer.
Abbott Point of Care
CS-2021-0012
Clinical Evaluation of pH, pCO2, pO2, Sodium, Potassium, Ionized Calcium, Glucose, and Hematocrit Tests in Venous and Arterial Specimens using the i-STAT CG8+ Cartridge on the i-STAT 1 Analyzer
Apellis Pharmaceuticals, Inc.
APL-COV-001
LABORATORY-BASED ASSESSMENT OF COMPLEMENT ACTIVATION IN PATIENTS WITH CONFIRMED CORONAVIRUS DISEASE (COVID-19)
Cue Health
CP-CoV2-001
Research Evaluation of the Cue™ SARS-CoV-2 Test
Cue Health
Cue CP-CoV2-HF_001
Evaluation of the Cue COVID-19 Test for Home and OTC Use for Human Factors/Usability.
Diasses (Lucria Health)
04A-CLI-002
A Multicenter Study to Evaluate the Performance of the Diassess Influenza A &
B Test in Point-of-Care Testing Sites.
Eli Lilly
J2W-MC-PYAB
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness
Eli Lilly
J2X-MC-PYAH
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants with Mild to Moderate COVID-19 Illness. Sponsor
Fujirebio Diagnostics, Inc
FDI-116
A Blood Collection from Patients Presenting with Suspected New Onset or Exacerbated Heart Failure.
Light AI Inc.
Light AI-COV-001-101
Study of Non-Invasive Light AI Device for the Diagnosis of COVID-19
LightAI
LightAI-COV-001-101
Study of Non-Invasive LightAI Device for the Diagnosis of COVID-19.
LightAI
Light AI 01-2021
Refinement of a Computer Algorithm using Smartphone Throat Images to Diagnose COVID-19.
Mesa Biotech
CS-FLU16-01
A Multicenter Study Conducted to Evaluate the Performance of the Mesa Biotech Flu A/Flu B Test in Laboratory and Point of Care Testing Sites
NIAID; Eli Lilly; AbCellera Biologics
ACTIV-2/A5401
Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID).
PerkinElmer, Inc.
R01-21001
PerkinElmer® COVID-19 Antigen Test Clinical Study (POC/CLIA-waived)
Pine Trees Health, Inc.
PTH-1233-01
A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care
Proof Diagnostics
n/a
A Feasibility Evaluation of Pine Trees Health Test System for Point-of-Care Users
bottom of page